These findings indicate that, compared with DSS-induced colitis, 7-KA treatment leads to an increase in foxp3+ Tregs, suggesting that 7-KA protects intestinal barrier integrity and alleviates colitis in mice, potentially through increased foxp3+ Tregs expression. This evidence concerns the gene FOXP3 and colitis.